215 related articles for article (PubMed ID: 25677009)
1. The clinical risk score predicts the effectiveness of adjuvant chemotherapy for colorectal liver metastasis.
Nakai T; Ishikawa H; Tokoro T; Okuno K
World J Surg; 2015 Jun; 39(6):1527-36. PubMed ID: 25677009
[TBL] [Abstract][Full Text] [Related]
2. The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator.
Ayez N; van der Stok EP; Grünhagen DJ; Rothbarth J; van Meerten E; Eggermont AM; Verhoef C
Eur J Surg Oncol; 2015 Jul; 41(7):859-67. PubMed ID: 25979624
[TBL] [Abstract][Full Text] [Related]
3. Preoperative FDG-PET-scan in patients with resectable colorectal liver metastases does not improve overall survival: a retrospective analyses stratified by clinical risk score.
Ayez N; de Ridder J; Wiering B; Oyen WJ; de Wilt JH; Verhoef C
Dig Surg; 2013; 30(4-6):451-8. PubMed ID: 24458160
[TBL] [Abstract][Full Text] [Related]
4. Reconsideration of the indications for adjuvant chemotherapy for liver metastases from colorectal cancer after initial hepatectomy.
Hirokawa F; Hayashi M; Miyamoto Y; Asakuma M; Shimizu T; Komeda K; Inoue Y; Uchiyama K
Ann Surg Oncol; 2014 Jan; 21(1):139-46. PubMed ID: 24121880
[TBL] [Abstract][Full Text] [Related]
5. The clinical relevance of the Fong and the Nordlinger scores in the era of effective neoadjuvant chemotherapy for colorectal liver metastasis.
Schreckenbach T; Malkomes P; Bechstein WO; Woeste G; Schnitzbauer AA; Ulrich F
Surg Today; 2015 Dec; 45(12):1527-34. PubMed ID: 25563588
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Unresectable Recurrence After Up-Front Surgery for Colorectal Liver Metastasis.
Hokuto D; Nomi T; Yasuda S; Yoshikawa T; Ishioka K; Yamada T; Akahori T; Nakagawa K; Nagai M; Nakamura K; Obara S; Kanehiro H; Sho M
World J Surg; 2018 Mar; 42(3):884-891. PubMed ID: 28879511
[TBL] [Abstract][Full Text] [Related]
7. Comparison between perioperative and postoperative chemotherapy after potentially curative hepatic resection for metastatic colorectal cancer.
Araujo R; Gonen M; Allen P; Blumgart L; DeMatteo R; Fong Y; Kemeny N; Jarnagin W; D'Angelica M
Ann Surg Oncol; 2013 Dec; 20(13):4312-21. PubMed ID: 23897009
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
Buisman FE; Homs MYV; Grünhagen DJ; Filipe WF; Bennink RJ; Besselink MGH; Borel Rinkes IHM; Bruijnen RCG; Cercek A; D'Angelica MI; van Delden OM; Donswijk ML; van Doorn L; Doornebosch PG; Emmering J; Erdmann JI; IJzerman NS; Grootscholten C; Hagendoorn J; Kemeny NE; Kingham TP; Klompenhouwer EG; Kok NFM; Koolen S; Kuhlmann KFD; Kuiper MC; Lam MGE; Mathijssen RHJ; Moelker A; Oomen-de Hoop E; Punt CJA; Te Riele WW; Roodhart JML; Swijnenburg RJ; Prevoo W; Tanis PJ; Vermaas M; Versleijen MWJ; Veuger FP; Weterman MJ; Verhoef C; Groot Koerkamp B
BMC Cancer; 2019 Apr; 19(1):327. PubMed ID: 30953467
[TBL] [Abstract][Full Text] [Related]
9. Short term and long term results of patients with colorectal liver metastases undergoing surgery with or without radiofrequency ablation.
van Amerongen MJ; van der Stok EP; Fütterer JJ; Jenniskens SF; Moelker A; Grünhagen DJ; Verhoef C; de Wilt JH
Eur J Surg Oncol; 2016 Apr; 42(4):523-30. PubMed ID: 26856957
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of
Shim JR; Lee SD; Han SS; Lee SJ; Lee DE; Kim SK; Kim SH; Park SJ; Oh JH
Eur J Surg Oncol; 2018 May; 44(5):670-676. PubMed ID: 29459018
[TBL] [Abstract][Full Text] [Related]
11. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
Bao Q; Wang K; Wang HW; Jin KM; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
[No Abstract] [Full Text] [Related]
12. Postoperative adjuvant chemotherapy is important for improving long-term survival in patients with colorectal cancer liver metastases undergoing simultaneous resection.
Zhong W; Xu B; Lu Y; Chang J; Xu L; Zhao H; Che X
J Gastroenterol Hepatol; 2024 May; 39(5):908-919. PubMed ID: 38323685
[TBL] [Abstract][Full Text] [Related]
13. Hepatic pedicle clamping during hepatic resection for colorectal liver metastases: no impact on survival or hepatic recurrence.
Weiss MJ; Ito H; Araujo RL; Zabor EC; Gonen M; D'Angelica MI; Allen PJ; DeMatteo RP; Fong Y; Blumgart LH; Jarnagin WR
Ann Surg Oncol; 2013 Jan; 20(1):285-94. PubMed ID: 22868921
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil to lymphocyte ratio predicts pattern of recurrence in patients undergoing liver resection for colorectal liver metastasis and thus the overall survival.
Giakoustidis A; Neofytou K; Khan AZ; Mudan S
J Surg Oncol; 2015 Mar; 111(4):445-50. PubMed ID: 25557840
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
[TBL] [Abstract][Full Text] [Related]
18. Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases.
Kumar R; Dennison AR; Robertson V; Jones MJ; Neal CP; Garcea G
ANZ J Surg; 2018 Jan; 88(1-2):E16-E20. PubMed ID: 27621179
[TBL] [Abstract][Full Text] [Related]
19. The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.
Hokuto D; Nomi T; Yamato I; Yasuda S; Obara S; Yoshikawa T; Kawaguchi C; Yamada T; Kanehiro H; Nakajima Y
J Surg Oncol; 2016 Dec; 114(8):959-965. PubMed ID: 27683191
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of positive surgical margins after resection of colorectal cancer liver metastases: reappraisal in the era of modern chemotherapy.
Tranchart H; Chirica M; Faron M; Balladur P; Lefevre LB; Svrcek M; de Gramont A; Tiret E; Paye F
World J Surg; 2013 Nov; 37(11):2647-54. PubMed ID: 23982776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]